Merck & Co., Inc. Deferred Income Tax Expense (Benefit)
Merck & Co., Inc. (MRK) reported Deferred Income Tax Expense (Benefit) of -$859.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-07
- Merck & Co., Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$544.00M.
- Merck & Co., Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$315.00M.
- Merck & Co., Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$825.00M.
- Merck & Co., Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$212.00M.
- Merck & Co., Inc. deferred income tax expense (benefit) for fiscal 2025 was -$1.67B.
- Merck & Co., Inc. deferred income tax expense (benefit) for fiscal 2024 was -$1.25B.
- Merck & Co., Inc. deferred income tax expense (benefit) for fiscal 2023 was -$1.90B.
- Merck & Co., Inc. deferred income tax expense (benefit) for fiscal 2022 was -$1.57B, a 938.50% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$544.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$859.00M 10-Q · filed 2026-08-07 | -$1.68B derived: sum of 3 quarters · filed 2026-08-07 | -$1.90B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$315.00M 10-Q · filed 2026-05-04 | -$1.14B derived: sum of 2 quarters · filed 2026-05-04 | -$1.35B derived: sum of 3 quarters · filed 2026-05-04 | -$1.80B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$825.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.04B derived: sum of 2 quarters · filed 2026-02-24 | -$1.49B derived: sum of 3 quarters · filed 2026-08-07 | -$1.67B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$212.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$660.00M derived: sum of 2 quarters · filed 2026-08-07 | -$846.00M 10-Q · filed 2025-11-05 | -$1.46B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$448.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$634.00M 10-Q · filed 2026-08-07 | -$1.25B derived: sum of 3 quarters · filed 2026-08-07 | -$1.65B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$186.00M 10-Q · filed 2026-05-04 | -$802.00M derived: sum of 2 quarters · filed 2026-05-04 | -$1.20B derived: sum of 3 quarters · filed 2026-05-04 | -$1.38B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$616.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.02B derived: sum of 2 quarters · filed 2026-02-24 | -$1.20B derived: sum of 3 quarters · filed 2026-02-24 | -$1.25B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$401.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$582.00M derived: sum of 2 quarters · filed 2025-11-05 | -$633.00M 10-Q · filed 2025-11-05 | -$1.56B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$181.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$232.00M 10-Q · filed 2025-08-05 | -$1.16B derived: sum of 3 quarters · filed 2026-02-24 | -$1.50B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$51.00M 10-Q · filed 2025-05-02 | -$982.00M derived: sum of 2 quarters · filed 2026-02-24 | -$1.32B derived: sum of 3 quarters · filed 2026-02-24 | -$1.67B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$931.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.27B derived: sum of 2 quarters · filed 2026-02-24 | -$1.62B derived: sum of 3 quarters · filed 2026-02-24 | -$1.90B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$336.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$691.00M derived: sum of 2 quarters · filed 2024-11-06 | -$968.00M 10-Q · filed 2024-11-06 | -$1.27B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$355.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$632.00M 10-Q · filed 2024-08-05 | -$939.00M derived: sum of 3 quarters · filed 2025-02-25 | -$1.60B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | -$277.00M 10-Q · filed 2024-05-03 | -$584.00M derived: sum of 2 quarters · filed 2025-02-25 | -$1.25B derived: sum of 3 quarters · filed 2025-02-25 | -$1.51B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$307.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$968.00M derived: sum of 2 quarters · filed 2025-02-25 | -$1.23B derived: sum of 3 quarters · filed 2025-02-25 | -$1.57B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$661.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$923.00M derived: sum of 2 quarters · filed 2023-11-03 | -$1.26B 10-Q · filed 2023-11-03 | -$1.10B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | -$262.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$600.00M 10-Q · filed 2023-08-07 | -$441.00M derived: sum of 3 quarters · filed 2024-02-26 | -$442.00M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | -$338.00M 10-Q · filed 2023-05-05 | -$179.00M derived: sum of 2 quarters · filed 2024-02-26 | -$180.00M derived: sum of 3 quarters · filed 2024-02-26 | -$169.00M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $159.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $158.00M derived: sum of 2 quarters · filed 2024-02-26 | $169.00M derived: sum of 3 quarters · filed 2024-02-26 | $187.00M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $10.00M derived: sum of 2 quarters · filed 2022-11-03 | $28.00M 10-Q · filed 2022-11-03 | -$570.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $29.00M 10-Q · filed 2022-08-05 | -$569.00M derived: sum of 3 quarters · filed 2023-02-24 | -$638.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $18.00M 10-Q · filed 2022-05-05 | -$10.00M 10-Q · filed 2021-05-05 | -$580.00M derived: sum of 2 quarters · filed 2023-02-24 | -$649.00M derived: sum of 3 quarters · filed 2023-02-24 | -$630.00M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | -$598.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$667.00M derived: sum of 2 quarters · filed 2023-02-24 | -$648.00M derived: sum of 3 quarters · filed 2023-02-24 | -$566.00M 10-K · filed 2023-02-24 | -$668.00M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$50.00M derived: sum of 2 quarters · filed 2021-11-05 | $32.00M 10-Q · filed 2021-11-05 | $47.00M 10-Q · filed 2020-11-05 | -$142.00M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $101.00M 10-Q · filed 2021-08-09 | $122.00M 10-Q · filed 2020-08-05 | -$73.00M derived: sum of 3 quarters · filed 2022-02-25 | -$310.00M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | $82.00M 10-Q · filed 2021-05-05 | -$92.00M derived: sum of 2 quarters · filed 2022-02-25 | -$329.00M derived: sum of 3 quarters · filed 2022-02-25 | -$672.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | -$174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$411.00M derived: sum of 2 quarters · filed 2022-02-25 | -$754.00M derived: sum of 3 quarters · filed 2022-02-25 | -$560.00M 10-K · filed 2022-02-25 | -$556.00M 10-K · filed 2020-02-26 | |||
| 2019-09-30 | -$237.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$580.00M derived: sum of 2 quarters · filed 2020-11-05 | -$386.00M 10-Q · filed 2020-11-05 | -$504.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$343.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$149.00M 10-Q · filed 2020-08-05 | -$267.00M derived: sum of 3 quarters · filed 2021-02-25 | -$400.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $194.00M 10-Q · filed 2020-05-06 | $76.00M derived: sum of 2 quarters · filed 2021-02-25 | -$57.00M derived: sum of 3 quarters · filed 2021-02-25 | -$285.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$118.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$251.00M derived: sum of 2 quarters · filed 2021-02-25 | -$479.00M derived: sum of 3 quarters · filed 2021-02-25 | -$509.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$133.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$361.00M derived: sum of 2 quarters · filed 2019-11-05 | -$391.00M 10-Q · filed 2019-11-05 | -$2.41B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | -$228.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$258.00M 10-Q · filed 2019-08-06 | -$2.28B derived: sum of 3 quarters · filed 2020-02-26 | -$2.61B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | -$30.00M 10-Q · filed 2019-05-08 | -$2.05B derived: sum of 2 quarters · filed 2020-02-26 | -$2.38B derived: sum of 3 quarters · filed 2020-02-26 | -$2.60B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | -$2.02B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$2.35B derived: sum of 2 quarters · filed 2020-02-26 | -$2.57B derived: sum of 3 quarters · filed 2020-02-26 | -$2.62B 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | -$329.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$547.00M derived: sum of 2 quarters · filed 2018-11-06 | -$601.00M 10-Q · filed 2018-11-06 | -$2.06B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | -$218.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$272.00M 10-Q · filed 2018-08-07 | -$1.73B derived: sum of 3 quarters · filed 2019-02-27 | -$1.67B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | -$54.00M 10-Q · filed 2018-05-08 | -$1.51B derived: sum of 2 quarters · filed 2019-02-27 | -$1.46B derived: sum of 3 quarters · filed 2019-02-27 | -$1.50B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$1.40B derived: sum of 2 quarters · filed 2019-02-27 | -$1.45B derived: sum of 3 quarters · filed 2019-02-27 | -$1.52B 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.00M derived: sum of 2 quarters · filed 2017-11-07 | -$65.00M 10-Q · filed 2017-11-07 | $17.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$120.00M 10-Q · filed 2017-08-08 | -$38.00M derived: sum of 3 quarters · filed 2018-02-27 | -$501.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$70.00M 10-Q · filed 2017-05-09 | $12.00M derived: sum of 2 quarters · filed 2018-02-27 | -$451.00M derived: sum of 3 quarters · filed 2018-02-27 | -$655.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $82.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$381.00M derived: sum of 2 quarters · filed 2018-02-27 | -$585.00M derived: sum of 3 quarters · filed 2018-02-27 | -$764.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$463.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$667.00M derived: sum of 2 quarters · filed 2016-11-07 | -$846.00M 10-Q · filed 2016-11-07 | -$1.67B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$204.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$383.00M 10-Q · filed 2016-08-08 | -$1.21B derived: sum of 3 quarters · filed 2017-02-28 | -$1.74B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$179.00M 10-Q · filed 2016-05-09 | -$1.01B derived: sum of 2 quarters · filed 2017-02-28 | -$1.53B derived: sum of 3 quarters · filed 2017-02-28 | -$2.48B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$827.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$1.35B derived: sum of 2 quarters · filed 2017-02-28 | -$2.30B derived: sum of 3 quarters · filed 2017-02-28 | -$2.60B 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$527.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.47B derived: sum of 2 quarters · filed 2015-11-05 | -$1.77B 10-Q · filed 2015-11-05 | -$1.57B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$942.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$1.25B 10-Q · filed 2015-08-06 | -$1.04B derived: sum of 3 quarters · filed 2016-02-26 | -$1.26B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$304.00M 10-Q · filed 2015-05-07 | -$102.00M derived: sum of 2 quarters · filed 2016-02-26 | -$315.00M derived: sum of 3 quarters · filed 2016-02-26 | -$563.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $202.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$11.00M derived: sum of 2 quarters · filed 2016-02-26 | -$259.00M derived: sum of 3 quarters · filed 2016-02-26 | -$330.00M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$213.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$461.00M derived: sum of 2 quarters · filed 2014-11-10 | -$532.00M 10-Q · filed 2014-11-10 | $420.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | -$248.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$319.00M 10-Q · filed 2014-08-07 | $633.00M derived: sum of 3 quarters · filed 2015-02-27 | $715.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | -$71.00M 10-Q · filed 2014-05-08 | $881.00M derived: sum of 2 quarters · filed 2015-02-27 | $963.00M derived: sum of 3 quarters · filed 2015-02-27 | $639.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $952.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.03B derived: sum of 2 quarters · filed 2015-02-27 | $710.00M derived: sum of 3 quarters · filed 2015-02-27 | $669.00M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$242.00M derived: sum of 2 quarters · filed 2013-11-07 | -$283.00M 10-Q · filed 2013-11-07 | -$846.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | -$324.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$365.00M 10-Q · filed 2013-08-07 | -$928.00M derived: sum of 3 quarters · filed 2014-02-27 | -$1.06B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | -$41.00M 10-Q · filed 2013-05-09 | -$604.00M derived: sum of 2 quarters · filed 2014-02-27 | -$737.00M derived: sum of 3 quarters · filed 2014-02-27 | -$1.36B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | -$563.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$696.00M derived: sum of 2 quarters · filed 2014-02-27 | -$1.32B derived: sum of 3 quarters · filed 2014-02-27 | -$1.54B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | -$133.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$760.00M derived: sum of 2 quarters · filed 2012-11-09 | -$974.00M 10-Q · filed 2012-11-09 | -$1.32B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | -$627.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$841.00M 10-Q · filed 2012-08-07 | -$1.19B derived: sum of 3 quarters · filed 2013-02-28 | -$1.61B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | -$214.00M 10-Q · filed 2012-05-08 | -$563.00M derived: sum of 2 quarters · filed 2013-02-28 | -$987.00M derived: sum of 3 quarters · filed 2013-02-28 | -$1.46B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | -$349.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$773.00M derived: sum of 2 quarters · filed 2013-02-28 | -$1.24B derived: sum of 3 quarters · filed 2013-02-28 | -$1.09B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$424.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$895.00M derived: sum of 2 quarters · filed 2011-11-08 | -$743.00M 10-Q · filed 2011-11-08 | -$742.80M 10-Q · filed 2010-11-08 | -$831.20M derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-06-30 | -$471.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$319.00M 10-Q · filed 2011-08-08 | -$318.90M 10-Q · filed 2010-08-06 | -$407.20M derived: sum of 3 quarters · filed 2012-02-28 | $852.60M derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-03-31 | $152.00M 10-Q · filed 2011-05-09 | $152.20M 10-Q · filed 2010-05-07 | $63.80M derived: sum of 2 quarters · filed 2012-02-28 | $1.32B derived: sum of 3 quarters · filed 2012-02-28 | $1.82B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | -$88.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.17B derived: sum of 2 quarters · filed 2012-02-28 | $1.67B derived: sum of 3 quarters · filed 2012-02-28 | $1.82B 10-K · filed 2012-02-28 | $1.82B 10-K · filed 2010-03-01 | |||
| 2009-09-30 | $1.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $1.76B derived: sum of 2 quarters · filed 2010-11-08 | $1.91B 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $495.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $649.40M 10-Q · filed 2010-08-06 | ||||||
| 2009-03-31 | $153.60M 10-Q · filed 2010-05-07 | |||||||
| 2008-12-31 | $530.00M 10-K · filed 2011-02-28 | $530.10M 10-K · filed 2010-03-01 | ||||||
| 2007-12-31 | -$1.78B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |